Analyses / NKE
Dividend-rich apparel leader grapples with -3.2% revenue decline, 30% China sales drop, and macro softness. Trading 46% below 52-week high.
A free account reveals NKE's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.
The Thesis
▲ Bull Case
20.4x P/E, 3.8% dividend yield (77% payout), improving insider buy-to-sell ratio (1.27x), modest cash position support dividend. If supply normalization and consumer spending stabilize, upside to mid-to-high 50s plausible. Gross margin (43%) remains healthy despite topline pressure.
▼ Bear Case
Revenue declining YoY (-3.2%), EPS growth -13.4% YoY and -10% over 5Y. China sales fell 30%, a critical market. Price-to-FCF 29x signals cash generation lagging valuation, and weak 8.2% op margin reflects competitive/macro stress. High payout ratio (77%) leaves little buffer if profits erode further.
Valuation
FAIRLY PRICED / SLIGHT DISCOUNT — score 68/100
P/E 20.4x is reasonable for a mature apparel play but elevated given negative growth momentum. P/S 1.37x is in-line with historical range. Price-to-FCF 29x signals cash yield weak vs earnings, raising quality concerns. Dividend yield 3.8% attractive for income, but payout ratio 77% leaves limited margin for earnings setbacks.
Technical Levels
Support · $40.00 (52-week low) · $38.50 (Technical floor (2024 support)) · $43.00 (Prev close / short-term support)
Resistance · $50.00 (Psychological round; 2-year avg) · $55.00 (Test of declining 200-day MA) · $65.00 (Pre-China-crisis level (2023)) · $80.17 (52-week high)
Financial Health
Score 72/100. Liquidity strong (current 1.96, quick 1.19). Balance sheet appears sound with adequate working capital. Debt metrics unavailable but large-cap status & dividend history suggest manageable leverage. No acute solvency risk; longer-term earnings pressure is the concern.
Catalysts
| Q3 2024 Earnings (late Oct/early Nov) | ~6-8 weeks | HIGH — will show whether China decline moderating, inventory normalizing, margins recovering. Beat/miss & guidance will drive multi-month directional move. |
| China consumer spending data & policy stimulus | Ongoing | HIGH — 30% sales drop YoY is biggest headwind. Any stabilization signal critical to stock re-rating. |
| Consumer spending & holiday retail data | Q4 2024 | MEDIUM — shapes FY2025 guidance; sets tone for 2024 reacceleration narrative. |
| Dividend announcement / payout ratio review | Next earnings or investor day | MEDIUM — high payout ratio (77%) means dividend cut is a risk if earnings weaken further. Maintenance signals confidence. |
Risk Flags
See NKE's full trade plan — free
Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.
Unlock NKE free →Recent News
- Nike was once China's sneaker king. Here's why its sales have fallen 30%CNBC
- Nike (NKE) Stock Looks Cheap On Earnings But Pricey On Cash FlowYahoo
- Nike's High Profile Visibility Can be a Boon and Sometimes a Legal CurseYahoo
- VF Shares Tumble After Reporting Wider-Than-Expected Fiscal First-Quarter LossYahoo
- Wednesday's session: top gainers and losers in the dow jones indexChartMill
You've read your 2 free analyses
Create a free account for unlimited analyses — every name on the page, plus live tools on 5,000+ tickers. No card required.
Read the full NKE analysis — free →Free to read · 2 analyses every 30 days without an account
More Analyses
NKE FAQ
Is NKE a buy right now?
Nike Inc's current read is a Value + Income / Recovery watch setup with 62 confidence over a 3-6 months horizon. Valuation: FAIRLY PRICED / SLIGHT DISCOUNT. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.
Is NKE overvalued?
FAIRLY PRICED / SLIGHT DISCOUNT (valuation score 68/100). P/E 20.4x is reasonable for a mature apparel play but elevated given negative growth momentum. P/S 1.37x is in-line with historical range. Price-to-FCF 29x signals cash yield weak vs earnings, raising quality concerns. Dividend yield 3.8% attractive for income, but payout ratio 77% leaves limited margin for earnings setbacks.
What are the risks of buying NKE?
Revenue declining YoY (-3.2%), EPS growth -13.4% YoY and -10% over 5Y. China sales fell 30%, a critical market. Price-to-FCF 29x signals cash generation lagging valuation, and weak 8.2% op margin reflects competitive/macro stress. High payout ratio (77%) leaves little buffer if profits erode further.